Literature DB >> 23566037

Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality.

Nick Wlazlo1, Marleen M van Greevenbroek, Joyce Curvers, Erik J Schoon, Pieter Friederich, Jos W R Twisk, Bert Bravenboer, Coen D A Stehouwer.   

Abstract

DM (diabetes mellitus) is present in 20-40% of patients with liver cirrhosis, but its prognostic impact is unclear. Therefore, in the present study, we investigated whether the presence of DM in patients with cirrhosis was associated with increased mortality, and/or with increased incidence of SBP (spontaneous bacterial peritonitis). We reviewed medical and laboratory data of 230 patients with cirrhosis from the period 2001-2011, for whom data were complete in n=226. Follow-up for the outcomes mortality and SBP was performed until May 2012, with only 13 patients lost to follow-up. DM was present at baseline in 78 patients (35%). Median follow-up was 6.2 (interquartile range, 3.1-9.3) years, during which 118 patients died [47 out of 78 with DM (60%), and 71 out of 148 without DM (48%)]. The presence of DM at baseline was not associated with increased mortality after adjustment for age {HR (hazard ratio), 1.00 [95% CI (confidence interval), 0.67-1.50]}. Further adjustment for sex, aetiology of cirrhosis, platelet count and the Child-Pugh or MELD (model for end-stage liver disease) score did not change this finding. During follow-up, 37 patients developed incident SBP (19 with DM and 18 without DM). DM at baseline was associated with incident SBP, even after adjustment for age, sex, aetiology, platelet count and the Child-Pugh [HR, 2.39 (95% CI, 1.10-5.18)] or MELD score [HR, 2.50 (95% CI, 1.16-5.40)]. In conclusion, the presence of DM at baseline in patients with cirrhosis was associated with an increased risk of SBP, which may represent an increased susceptibility to infections. On the other hand, DM was not clearly associated with increased mortality in these patients.

Entities:  

Mesh:

Year:  2013        PMID: 23566037     DOI: 10.1042/CS20120596

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

1.  Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.

Authors:  Xiaodan Zhang; William S Harmsen; Teresa A Mettler; W Ray Kim; Rosebud O Roberts; Terry M Therneau; Lewis R Roberts; Roongruedee Chaiteerakij
Journal:  Hepatology       Date:  2014-07-31       Impact factor: 17.425

2.  Salvianolate Reduces Glucose Metabolism Disorders in Dimethylnitrosamine-Induced Cirrhotic Rats.

Authors:  Li-Rui Tang; Yan-Yan Tao; Cheng-Hai Liu; Hai-Nan Wang
Journal:  Chin J Integr Med       Date:  2017-12-05       Impact factor: 1.978

3.  Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.

Authors:  Tsai-Ling Liu; Justin Trogdon; Morris Weinberger; Bruce Fried; A Sidney Barritt
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

Review 4.  Comorbidity in cirrhosis.

Authors:  Peter Jepsen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.

Authors:  Xu Li; Hongqin Xu; Yang Gao; Meng Pan; Le Wang; Pujun Gao
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis.

Authors:  Hiroshi Isoda; Hirokazu Takahashi; Yuichiro Eguchi; Motoyasu Kojima; Kanako Inoue; Kenichiro Murayama; Yayoi Matsuda; Keizo Anzai
Journal:  Biomed Rep       Date:  2016-11-10

7.  Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?

Authors:  Thazhath Mavali Ramachandran; Aninchent Harayil Rajan Rajneesh; George Sarin Zacharia; Rajendran P Adarsh
Journal:  J Clin Diagn Res       Date:  2017-09-01

8.  Type 2 diabetes mellitus increases liver transplant-free mortality in patients with cirrhosis: A systematic review and meta-analysis.

Authors:  Zi-Jin Liu; Yi-Jie Yan; Hong-Lei Weng; Hui-Guo Ding
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

9.  Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites.

Authors:  Tammo L Tergast; Hans Laser; Svetlana Gerbel; Michael P Manns; Markus Cornberg; Benjamin Maasoumy
Journal:  Clin Transl Gastroenterol       Date:  2018-09-24       Impact factor: 4.488

Review 10.  Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis.

Authors:  Ramesh Kumar
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.